Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment showed a higher response rate but no significant survival benefits.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Moles may stop growing because of cell cooperation, not just because of aging cells.

Thymic LCH may be underdiagnosed, so thymic ultrasound should be considered in infants with cutaneous LCH.

Moles may stop growing due to cell cooperation, not just because of individual cell aging.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

BAP1 mutations are rare in pediatric melanocytic tumors and may develop later in life.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Male hair loss is mainly due to thinner hair, not less hair.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Cancer treatments often cause skin, nail, and hair problems.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Scalp melanoma is often diagnosed late in people with hair loss, leading to worse outcomes.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.